EN
HI
Dr Agarwal's Health Care. Share price
AGARWALEYE
506.5
2.00 (-0.39%)NSE
BSE
Last updated on 14 Aug, 2026 | 15:54 IST
Dr Agarwal's Health Care share price chart
Dr Agarwal's Health Care. Share Key Metrics
Volume
5.64 L
Market Cap
16055.19 CR
LTQ@LTP
15@506.50
ATP
507.62
Var Margin
14.31 %
Circuit Range
405.2-607.8
Delivery %
60.93 %
Value
28.63 CR
ASM/GSM
No
Market Lot
1
Summary
AGARWALEYE stock price is ₹506.5 as of 15 Aug, 2026. The stock intraday movement has stayed between ₹502.00 and ₹511.40, while Dr Agarwal's Health Care. share price 52 week high low is ₹401.00 & ₹568.00.
In terms of trading activity, AGARWALEYE share price has recorded a volume of 5,64,021 shares. The Dr Agarwal's Health Care. has a market cap of ₹316983028. The stock’s Average Traded Price (ATP) stands at ₹507.62, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 15 @ ₹506.50.
The Dr Agarwal's Health Care. upper circuit limit is ₹607.80 & The Dr Agarwal's Health Care. lower circuit limit is ₹405.20, with a Value of ₹28.63 CR. The Delivery Percentage for the day is 60.93%.
Additionally, the share currently falls under the No framework, and trades with a market lot size of ₹1.
Dr Agarwal's Health Care. Resistance and Support
Pivot 504.4
Resistance
First Resistance
515.2
Second Resistance
521.9
Third Resistance
532.7
Support
First Support
497.7
Second Support
486.9
Third Support
480.2
Dr Agarwal's Health Care. Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-04 | Quarterly Results |
| 2026-05-21 | Audited Results |
| 2026-02-03 | Quarterly Results |
| 2025-10-30 | Quarterly Results |
| 2025-08-12 | Quarterly Results |
| 2025-05-28 | Audited Results |
| 2025-02-14 | Quarterly Results |
Dr Agarwal's Health Care. News
Dr. Agarwals Health Care Ltd - 544350 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Claymore Investments (Mauritius) Pte. Ltd., along with its PAC Arvon Investments Pte. Ltd., sold 1.59 crore equity shares of Dr. Agarwal's Health Care Limited, reducing their combined shareholding by 5.02% to 15.04%. The transaction was executed via the open market.
Aug 14 2026 14:42:58
Dr. Agarwals Health Care Ltd - 544350 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Hyperion Investments Pte. Ltd., a significant shareholder in Dr. Agarwal's Health Care, sold 2.41 crore shares. This disposal reduced its holding from 23.09% to 15.47% through open market transactions.
Aug 14 2026 11:55:30
Dr. Agarwals Health Care Ltd - 544350 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
Invesco Mutual Fund has increased its aggregate holding in Dr. Agarwal's Health Care to 5.2125% of the paid-up share capital, up from 3.0240% previously. This stake was acquired through open market purchases, signaling increased institutional confidence.
Aug 14 2026 11:52:31
Dr. Agarwals Health Care Ltd - 544350 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Dr. Agarwal's Health Care reported that Catalyst Trusteeship Limited has released encumbrance on 31,698,303 equity shares, which is 10.00% of the company's total share capital. This reduces the total encumbered shares to 13.09%.
Aug 14 2026 11:47:36
Dr. Agarwals Health Care Ltd - 544350 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
ICICI Prudential Mutual Fund acquired 1.70 crore shares of Dr. Agarwal's Health Care on August 12, 2026. This acquisition increased their total stake to 5.36% of the company's paid-up capital.
Aug 14 2026 11:38:46
Dr. Agarwals Health Care Ltd - 544350 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Dr. Agarwal's Health Care has released the audio recording of its Analyst/Earnings Conference Call, held on August 4, 2026. The recording, which discusses the Q1 FY27 unaudited financial results, is accessible on the company's website for investors.
Aug 04 2026 19:01:27
Dr. Agarwals Health Care Ltd - 544350 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report
Dr. Agarwal's Health Care's Monitoring Agency Report confirms that the utilization of IPO proceeds for Q1 FY27 has no material deviation from the stated objects. This indicates adherence to IPO object disclosures and efficient fund management.
Aug 04 2026 14:22:01
Dr. Agarwals Health Care Ltd - 544350 - Board Meeting Intimation for Consideration And Approval Of The Unaudited Financial Results (Standalone And Consolidated) Of The Company For The Quarter Ended June 30, 2026
Dr. Agarwal's Health Care Board is scheduled to meet on August 04, 2026, to consider and approve the Q1 FY27 financial results. The company will also host an earnings/analyst conference call on the same day.
Jul 28 2026 18:59:02
Dr. Agarwals Health Care Ltd - 544350 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Dr. Agarwal's Health Care Ltd. disclosed the NCLT has scheduled a hearing on August 19, 2026, for its proposed scheme of amalgamation. This is a procedural step for the merger of Dr. Agarwal's Eye Hospital Limited and Dr. Agarwal's Health Care Limited.
Jul 20 2026 17:32:51
Read More
Dr Agarwal's Health Care. Management
| Name | Position |
|---|---|
| Thanikainathan Arumugam | Company Secretary & Compliance Officer |
| Adil Agarwal | Whole Time Director & Chief Executive Officer |
Dr Agarwal's Health Care. Similar Stocks
Poly Medicure Ltd.
1786.20
-26.60 (1.47%)
Onesource Specialty Pharma Ltd.
1559.20
-12.10 (0.77%)
Natco Pharma Ltd.
903.15
-48.55 (5.10%)
Cohance Lifesciences Ltd.
440.65
-3.55 (0.80%)
Alembic Pharmaceuticals Ltd.
831.25
0.05 (0.01%)
Shilpa Medicare Ltd.
822.00
14.95 (1.85%)
Vijaya Diagnostic Centre Ltd.
1474.10
-12.40 (0.83%)
Concord Biotech Ltd.
1451.30
-3.20 (0.22%)
Rainbow Children's Medicare Ltd.
1461.80
8.80 (0.61%)
Jubilant Pharmova Ltd.
865.80
-24.70 (2.77%)
Dr Agarwal's Health Care. FAQs
The Buying Price of Dr Agarwal's Health Care. share is 506.5 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Dr Agarwal's Health Care. stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Dr Agarwal's Health Care., choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Dr Agarwal's Health Care. shares is 108.14. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Dr Agarwal's Health Care. shares is 7.71. Useful to assess the stock's value relative to its book value.
To assess Dr Agarwal's Health Care.’s valuation compare Sector P/E, P/B which are 54.06 & -14.52 with sector averages, along with growth rates and financial metrics.
The Market Cap of Dr Agarwal's Health Care. is 16055.19 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Dr Agarwal's Health Care. share price is 568.00 & 401.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Dr Agarwal's Health Care. belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Invest in AGARWALEYE
Account Opening Fee
AMC for 1st Year
Auto Square Off Charges
Call & Trade
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
Or Download Choice FinX App
Invest in AGARWALEYE
Account Opening Fee
AMC for 1st Year
Auto Square Off Charges
Call & Trade